Compugen (Israel)
Compugen Ltd. is a clinical-stage publicly traded predictive drug discovery and development company headquartered in Israel, with shares traded on the NASDAQ Capital Market and on the Tel Aviv Stock Exchange. Compugen was established as computational drug discovery service provider in 1993. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Compugen (Israel), Israel, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
48%
Total
Publications
186
Total Open
Publications
89
Total
Citations
16K
Open Access
Percentage
48%
Total
Publications
186
Total Open
Publications
89
Total
Citations
16K
Breakdown
Publisher Open
20%
Both
18%
Other Platform Open
10%
Closed
52%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 48%
33
Hybrid 30%
21
No Guarantees 22%
15
Other Platform Open
Domain 52%
27
Other Internet 40%
21
Preprint 19%
10
Institution 12%
6
Public 8%
4
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 25 |
DOI | Other Internet | 21 |
arXiv | Preprint | 8 |
Figshare | Public | 3 |
Europe PMC | Domain | 3 |
King Abdullah University of Science and Technology | Institution | 2 |
bioRxiv | Preprint | 2 |
Zenodo | Public | 1 |
University of Vienna | Institution | 1 |
University of Turku | Institution | 1 |